open access
Role of [18F]FDG PET/CT in the differential diagnosis of a supraclavicular lump: neurofibromatosis disease
, 2, 3, 4, 1
Affiliations- Servicio de Medicina Nuclear, Hospital Universitario Virgen Macarena, Sevilla, Spain
- Servicio de Medicina Nuclear, Hospital Universitario Puerta del Mar, Cadiz, Spain
- Servicio de Anatomia Patologica, Hospital Universitario Virgen Macarena, Sevilla, Spain
- Servicio de Cirugía General, Hospital de Merida, Badajoz, Spain
open access
Abstract
We report a 31-year-old male with a history of left forearm neuroma surgically removed, consulting for a supraclavicular bultoma congruent with the supradiaphragmatic lymphoproliferative syndrome in computed tomography (CT) scan. [18F]FDG PET/CT images helped to establish the most diagnostic yield lesion for the biopsy, and allowed an accurate staging of the neurofibromatosis (NF) disease, leading to the most appropriate therapeutic option for the patient.
Abstract
We report a 31-year-old male with a history of left forearm neuroma surgically removed, consulting for a supraclavicular bultoma congruent with the supradiaphragmatic lymphoproliferative syndrome in computed tomography (CT) scan. [18F]FDG PET/CT images helped to establish the most diagnostic yield lesion for the biopsy, and allowed an accurate staging of the neurofibromatosis (NF) disease, leading to the most appropriate therapeutic option for the patient.
Keywords
[18F]FDG; NF; PET/CT; neurofibroma; differential diagnosis; bultoma
About this articleTitle
Role of [18F]FDG PET/CT in the differential diagnosis of a supraclavicular lump: neurofibromatosis disease
Journal
Issue
Vol 26 (2023): Continuous Publishing
Article type
Clinical vignette
Pages
40-41
Published online
2022-10-28
Page views
2812
Article views/downloads
273
DOI
Bibliographic record
Nucl. Med. Rev 2023;26:40-41.
Keywords
[18F]FDG
NF
PET/CT
neurofibroma
differential diagnosis
bultoma
Authors
Ana Moreno-Ballesteros
María De Bonilla-Candau
Javier Mohigefer
Marta Moreno-Ballesteros
Francisco Javier Garcia-Gomez
References (9)- Ferner R, OʼDoherty M. Neurofibroma and schwannoma. Curr Opin Neurol. 2002; 15(6): 679–684.
- Strike SA, Puhaindran ME. Nerve tumors of the upper extremity. Clin Plast Surg. 2019; 46(3): 347–350.
- Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology. 2003; 229(1): 3–8.
- Mantaka P, Strauss AD, Moehler M, et al. Detection of treated liver metastases using fluorine-18-fluordeoxyglucose (FDG) and positron emission tomography (PET). Anticancer Res. 1999; 19: 4443–4450.
- Chirindel A, Chaudhry M, Blakeley JO, et al. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization. J Nucl Med. 2015; 56(3): 379–385.
- Van Der Gucht A, Zehou O, Djelbani-Ahmed S, et al. Metabolic tumour burden measured by 18F-FDG PET/CT predicts malignant transformation in patients with neurofibromatosis type-1. PLoS One. 2016; 11(3): e0151809.
- Ahlawat S, Blakeley J, Montgomery E, et al. Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging. Skeletal Radiol. 2013; 42(9): 1317–1322.
- Brinkman M, Jentjens S, Boone K, et al. Evaluation of the most commonly used (semi-)quantitative parameters of 18F-FDG PET/CT to detect malignant transformation of neurofibromas in neurofibromatosis type 1. Nucl Med Commun. 2018; 39(11): 961–968.
- Gross AM, Wolters PL, Dombi E, et al. Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med. 2020; 382(15): 1430–1442.
